Market Tracker

04/17 6:02pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

7.18
Delayed Data
As of Apr 17
 0.00 / 0.00%
Today’s Change
6.52
Today|||52-Week Range
10.26
-6.87%
Year-to-Date

Today’s Trading

Previous close7.18
Today’s open7.16
Day’s range7.10 - 7.29
Volume8,703,173
Average volume (3 months)3,731,628
Market cap$1.2B
Dividend yield8.36%
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+18.28%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.9
Price/Sales2.10
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.18-2.58%
KPTIKaryopharm Therapeut...-1.04-2.99%
ACHNAchillion Pharmaceut...-0.29-2.75%
FOLDAmicus Therapeutics ...+0.06+0.50%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts